VIDEO: Treating HCV in pregnancy may reduce risk for mother-to-child transmission

ByNorah Terrault, MD, MPH, FAASLD

ByMarley V. Ghizzone

Fact checked byHeather Biele

BOSTON — Healio spoke with Norah Terrault, MD, MPH, FAASLD, about presentations from The Liver Meeting that investigated testing and treatment of hepatitis C virus infection among pregnant individuals.

“The current therapies we have for hepatitis C are not approved for use in pregnancy, and yet we understand that pregnancy is often a time when women come into care, maybe newly diagnosed at that time,” Terrault, professor of medicine, chief of gastroenterology and liver diseases, and Neil Kaplowitz Endowed Chair in Liver Diseases Research at the University of Southern California Keck School of Medicine, said.

Published by:

Sources/Disclosures

Collapse

Source:

Healio Interviews

Disclosures: Terrault reports receiving institutional grant support from NIH; institutional grant support for clinical trials from Durect Corp., Eiger Pharmaceuticals, Genentech-Roche, Gilead Sciences, GSK, Helio Health and Madrigal; honoraria for speaking at conferences or other lectures from AASLD, The Asian Pacific Association for the Study of the Liver, Canadian Association for the Study of the Liver (CASL), Duke University, EASL, International Liver Transplantation Society (ILTS), GUILD Conference, Houston Methodist, Iowa University, University of Alabama at Birmingham and University of California; travel accommodations for lectures from AASLD, CASL, EASL, GUILD, ILTS, Iranian Association for the Study of Liver Diseases and Pakistan Society For The Study Of Liver Diseases; serving as president on the governing board of AASLD; serving as a steering committee member for Hepatitis B Foundation and HBV Forum; and being provided with educational materials from Clinical Care Options and Simply Speaking.

Take Homes in HCV

Read more

VIDEO: Treating HCV in pregnancy may reduce risk for mother-to-child transmission

Related Content